Can a patient stop taking insulin after a pancreatic islet cell transplant?

Following a pancreatic islet cell transplant, some patients with type 1 diabetes may be able to reduce their need for insulin injections or stop them entirely. This transplant aims to restore the body's natural ability to produce insulin, which improves blood glucose levels and reduces severe hypoglycemia episodes. However, not all patients achieve complete independence from insulin; some may only require lower doses.

Islet cell transplantation is a therapeutic option for certain adults with type 1 diabetes who struggle to manage blood glucose levels and experience frequent, severe hypoglycemic episodes despite intensive diabetes management and education [1]. It is important to understand that this procedure requires a lifelong commitment to taking immunosuppressive medications to prevent the body from rejecting the transplanted cells [2].

Success in Stopping Insulin

Studies have shown that islet cell transplantation can reduce or eliminate the need for insulin injections. One year after islet cell transplantation, nearly half of recipients were able to stop taking insulin entirely. After two years, approximately 4 out of 10 recipients continued to be insulin-independent [1]. Even patients who continued to require insulin after the transplant experienced significant improvements in their diabetes-related quality of life and overall health status [1].

In addition to reducing the need for insulin, the transplant helps improve blood glucose levels, reduces or prevents severe hypoglycemic episodes, and improves awareness of hypoglycemia symptoms [1]. This improvement contributes to reducing the risk of diabetes-related complications such as heart disease, kidney disease, and nerve or eye damage [1].

The Importance of Immunosuppressive Medications

After an islet cell transplant, recipients must take immunosuppressive medications for as long as the transplanted cells remain functional. These drugs prevent the body's immune system from attacking and destroying the transplanted islet cells [2]. If a patient stops taking these medications, the body will reject the transplanted cells, and they will stop functioning [1].

Immunosuppressive medications carry potential serious side effects, including an increased risk of infection and cancer, as well as digestive side effects such as nausea, vomiting, or diarrhea, headaches, tremors, high blood pressure, elevated blood glucose levels, high cholesterol and triglyceride levels, and kidney damage [1]. The patient must discuss these risks and benefits with their physician to determine if an islet cell transplant is the most appropriate option.

Practical Considerations and Individual Outcomes

The ability to stop or reduce insulin doses depends heavily on the individual's body response to the transplant. A patient may require more than one infusion of transplanted islet cells to achieve insulin independence [1]. Furthermore, the availability of donor pancreases is limited, making islet cell transplantation a rare treatment [1].

It is essential that the patient follows up with their medical team regularly after the transplant to monitor blood glucose levels, transplanted cell function, and side effects of the immunosuppressive medications. Patients interested in learning more about this procedure can visit Pancreatic Islet Cell Transplantation for Type 1 Diabetes (Arabic).

Medical references

• Pancreatic Islet Transplantation
• Islet Cell Transplantation